Sildenafil citrate, the active ingredient in Viagra, holds a unique and enduring position in the erectile dysfunction market. Despite facing intense generic competition following patent expirations over the past decade, the sildenafil segment continues to command the largest slice of the revenue pie, estimated at over $\$$1.5$ billion and retaining approximately $45\%$ to $57\%$ of the total market revenue in 2024. This sustained financial dominance, long after its initial brand exclusivity ended, is a significant phenomenon that speaks volumes about brand power and patient trust.

The drug's early market introduction and aggressive marketing campaigns established it as the widely recognized, even cultural, icon for ED treatment. This brand recognition translates into strong prescriber loyalty and patient preference, even when therapeutically equivalent, lower-priced generic versions are available. The reliable efficacy and well-understood side-effect profile of sildenafil make it the default choice for millions of men and the vast majority of physicians globally. Understanding the resilience of this segment requires a careful study of the factors underpinning the Sildenafil Citrate Revenue Share in the face of deep price erosion from generic competitors.

However, the segment's revenue is not solely reliant on the original branded product. Manufacturers have responded to generic pressure by introducing innovative proprietary formulations of sildenafil, such as dissolvable films or specific dosage strengths, which they market as premium, differentiated products. Furthermore, sildenafil’s proven utility in treating other conditions, such as pulmonary arterial hypertension, provides a stable, diversified revenue stream that fortifies its overall market standing.

As the market continues to diversify into regenerative therapies, sildenafil will likely remain the gold standard against which all new oral treatments are measured. Its legacy of being the first highly successful oral therapy ensures that even in an increasingly complex and competitive landscape, its revenue share will remain a formidable force, driven by decades of established trust and its ubiquitous presence across distribution channels.